1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Grants from Dennis & Phyllis Washington Foundation is sponsored by Dennis & Phyllis Washington Foundation. Grants from Dennis & Phyllis Washington Foundation help Montana and select Northwest nonprofits expand health and human services for disadvantaged populations. Cancer-focused organizations serving at-risk youth or low-income families may be eligible.
While not specific to HLRCC, a program addressing the needs of HLRCC patients within these demographics could potentially apply.
Get alerted about grants like this
Get emailed when new opportunities from “Dennis & Phyllis Washington Foundation” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Montana and select Northwest nonprofits are eligible, especially if their programs provide direct services and demonstrate strong community backing. Cancer-focused organizations serving at-risk youth or low-income families may be eligible. Confirm the full requirements in the official notice before applying.
Grants from Dennis & Phyllis Washington Foundation is funded by Dennis & Phyllis Washington Foundation. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Montana. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The Trump administration is renegotiating $33 billion in CHIPS Act grants, demanding equity stakes in Intel, Samsung, and TSMC. With only 24 of 161 milestones completed and applications still open, here is what the new terms mean for semiconductor manufacturers and supply chain companies.
Read articleThe 2026 UMR economic impact report shows NIH funding produced $94 billion in activity and nearly 400,000 jobs — while success rates hit a 30-year low. The strongest economic argument against cutting biomedical research funding, and what researchers should do now.
Read articleNIST launched a sweeping initiative to standardize how AI agents authenticate, interoperate, and stay secure. Companies building autonomous AI systems need to pay attention now.
Read article